HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vascular endothelial growth factor and recurrent spontaneous abortion: a meta-analysis.

Abstract
To evaluate the association between vascular endothelial growth factor (VEGF) gene polymorphisms and the risk of recurrent spontaneous abortion (RSA), a meta-analysis of published case-control studies for the VEGF gene polymorphisms (gene polymorphisms reported more than three times were selected) and the risk of RSA. Odds ratios (ORs) and 95% confidence intervals (CIs) for codominant, dominant and recessive genetic models were assessed by RevMan software. Eight studies with 2813 cases and 2830 controls were included in this meta-analysis. The pooled analysis showed that -2578C/A, -1154G/A polymorphisms of VEGF were not significantly associated with the risk of RSA neither under codominant model nor under dominant model, nor under recessive model. Whereas, for -634G/C polymorphism, the pooled OR and 95% CI were 1.23 (1.01-1.49) under recessive model; and for 936C/T polymorphism, the pooled OR and 95% CI were 1.34 (1.07-1.67) and 1.40 (1.09-1.80) under codominant and dominant models, respectively. This meta-analysis suggested that VEGF gene -2578C/A, -1154G/A polymorphisms were not significantly associated with the risk of RSA, whereas, -634G/C and +936C/T polymorphisms were associated with the risk of RSA under specific genetic models.
AuthorsBingzhen Zhang, Bingqin Dai, Xingliang Zhang, Zhiping Wang
JournalGene (Gene) Vol. 507 Issue 1 Pg. 1-8 (Oct 01 2012) ISSN: 1879-0038 [Electronic] Netherlands
PMID22766401 (Publication Type: Journal Article, Meta-Analysis)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
Topics
  • Abortion, Habitual (genetics)
  • Abortion, Spontaneous (genetics)
  • Female
  • Humans
  • Polymorphism, Genetic
  • Vascular Endothelial Growth Factor A (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: